CABENUVA Cabotegravir / Rilpivirine 600 mg - 900 mg Injection Single-Dose Kit 3 mL - 3 mL

Name: HIV Integrase Inhibitor and HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor
Brand: CABENUVA

McKesson #

1184408

Manufacturer #

49702024015

Brand

CABENUVA

Manufacturer

Glaxo Specialty

Country of Origin

Unknown

Application

HIV Integrase Inhibitor and HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor

Container Type

Single-Dose Kit

Dosage Form

Injection

Generic Drug Name

Cabotegravir / Rilpivirine

NDC Number

49702024015

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Storage Requirements

Requires Refrigeration

Strength

600 mg - 900 mg

Type

Intramuscular

UNSPSC Code

51343800

Volume

3 mL - 3 mL

CABENUVA is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine
Requires Refrigeration
Intramuscular (IM) gluteal